Who we are?

www.asamuel.eu

Partner in Life Science Industry

www.asamuel.eu

Who we are?

• Team of specialised experts

• All services for whole Europe in one place

• EU regulatory knowledge and strategies

• MA holding and support

• EU/local RA and PHV contact

www.asamuel.eu

Our Services• Continuous support and updates depending on EU legislation

• Regulatory services– Medicinal products, medical devices– Cosmetics, food supplements– Veterinary products

• Education + trainings

• Clinical Trials

• PASS - Post-Authorisation Safety Studies

• Marketing + sales– Import/Distribution– Marketing

www.asamuel.eu

RA Services = Regulatory House

www.asamuel.eu

Our Services – Key Features• Partner/Products/Concept analysis

– Identification of key issues and risks of market entry– Elaborating of possible scenarios and strategy alternatives

• Quantification of alternatives– Value, Time, Risks

• Evaluation of influence on– Product definition– Registration strategy– Pricing– Reimbursement– Follow up procedures

www.asamuel.eu

Scope of The Services in Regulatory Affairs

• Consultation and registration services in the territories– EU countries– Russia– Ukraine

• Strategy, Registration, Maintenance Services in– Human and veterinary medicinal products– All alternatives of registration procedures (National, CP,

MRP, DCP)– Food supplements and novel foods– Medical equipments/devices– „Health“ cosmetics

www.asamuel.eu

Registration Files - Submissions

– Compilation and evaluation– Completeness and quality check: pre-submission– Preparation of CTD files– Support in creating Module 1 for all procedures

according national/EU requirements– Negotiations with authorities– DCP slots blocking and management– Transforming/ creating of e-CTD format

www.asamuel.eu

e-CTD• The electronic Common Technical Document (e-CTD)

is an interface for the pharmaceutical industry to agency transfer of regulatory information. The content is based on the Common Technical Document (CTD) format.

• The e-CTD was developed by the ICH as standard format for regulatory submissions in the Europe, USA and Japan.

www.asamuel.eu

Registration Files - Text Management

Compliance in each country

– Patient Information Leaflet (PIL), Summary of Product Characteristics (SPC), packaging material (mock-ups)

– Harmonization of texts according to:• Actual QRD format• Local requirements• EU reference product (generics)

– Mock-up creation– Translation of texts to all languages– Braille requirements

The smooth pass of the texts

fundamental part of instant national phase of registration

www.asamuel.eu

Complex Regulatory Maintenance Management

– Variations– Communication with authorities– Renewals of MAs– Sunset clause monitoring and solving

Professional maintenance management saved time, stress, money …

www.asamuel.eu

Pharmacovigilance• Pharmacovigilance monitoring of the products 24/7/365

– Non-stop services for receipt of adverse events signals– Proprietary PHV database– Literature search service– Safety studies /clinical trials support

• Complex services of QPPV:– Creation and run of the PHV system according to current EU

requirements– Electronic submission of ADRs/AEs to EMA/NA (MedDRA,

EudraVig)– Compulsory regular PHV training of the staff– Electronic submission of product information to EMA database

(XEVMPD)

www.asamuel.eu

Other Services

• Public information service– 24/7/365 patient service – Disabled people

• Consultation services for – Patients– Health care professionals– Companies

The role of pharmacovigilance is becoming extremely important part of the daily business

www.asamuel.eu

Clinical Trials

www.asamuel.eu

Clinical Trial Preparation

• Feasibility studies, start-up support• Selection of qualified investigators and trial sites • Preparation of study documents (Protocol,

Investigator´s Brochure, Informed Consent Form, questionnaires, manuals etc.)

• Protocol and medical writing• Statistical support, clinical trial designing• Submission to regulatory authorities and ethics

committees• Co-ordination of preparation works, investigator´s

meeting

www.asamuel.eu

Monitoring and CT Management

• Site management, communication with investigators, on-site activities

• Trial monitoring in compliance with Good Clinical Practice (GCP) • Data management and statistical data processing• Identification of changes and evaluation of regulatory aspects• Supervision of the progress of a clinical trial• Support for fast recruitment• Ensuring protocol compliance• Applying SOPs, GCP and applicable regulatory requirements• Set up of adequate procedures for quality control and quality

assurance

www.asamuel.eu

Medical ServicesSupport of the investigators • Preparation of Standard Operating Procedures • Good Clinical Practice trainings• Good Laboratory Practice trainings• Good Manufacturing Practice for Advanced Therapies• Legal aspects of CT, data protection, insurance

Medical Services• Medical support of project teams• 24/7 medical support, ongoing medical safety review• Medical review of clinical study reports• Medical expert opinion• Medical reporting (interim, final reports, safety reports)

www.asamuel.eu

Pharmacovigilance , Risk Management

• QPPV service• Immediate report of serious adverse events to sponsor • Reporting of SUSARS and all safety issues to competent

authority and ethics committee • Submission of annual safety reports to competent

authority and ethics committee • Transmission of safety reports to investigators • Immediate hazard management• Risk management plan• Continuous follow-up and evaluation of risks• Quality assurance and Quality Control, QA/QC Audits

www.asamuel.eu

Post-Authorisation Safety Studies (PASS)• A post-authorisation safety study (PASS) is defined in Article 1(15) of

Directive 2001/83/EC as any study relating to an authorised medicinal product conducted with the aim of identifying, characterising or quantifying a safety hazard, confirming the safety profile of the medicinal product, or of measuring the effectiveness of risk-management measures.

• PASS are designed to ensure that medicinal products are monitored for long-term safety and effectiveness in Routine Clinical Practice and may be initiated, managed or financed by MAH voluntarily, or pursuant to an obligation imposed by a competent authority.

• PASS – Critical New Tool in searching for „Missing Information“

www.asamuel.eu

PASS - ServicesPASS Management• Definition of scientific format of protocols, abstracts and final study report

for non-interventional PASS• Identification of the Requirements and Key elements for PASS• Creating Guidance on Effectiveness of Risk Minimisation• Establishing monitoring system – GVP (Good Pharmacovigilance Practice)• E-register of non-interventional PASS maintained by the Agency• Publication of Final Study Report

PASS On-site services• ON-SITE preparation of PASS (including on-site training, contract issue etc.)• ON-SITE Data Management and Data Collection of PASS • e-CRFs services, Statistical analysis• Preparing FINAL Study Report

www.asamuel.eu

Education & Training

www.asamuel.eu

Education & Training

Regulatory affairs excellence is mainly driven by knowledge – let´s be up to date and learn effectively

– Life Cycle of Medicinal Products– Biostatistics – GCP course– Coordination of the clinical trials

All courses are provided in co-operation with PharmAround education platform

www.pharmaround.com

www.asamuel.eu

Marketing + Sales

www.asamuel.eu

Market Access• Market analysis and market environment • Market Access strategy – reflecting actual and upcoming

legislation development and „current“ practices• Pharmacoeconomic analysis

– Budget impact– Cost effectiveness– Cost containment…..

• Preparation and submission of application for– Maximum price– Reimbursement

• Organisation of „patient registries“• Management of „life cycle“ of the reimbursement/price

www.asamuel.eu

Committed to Your Success

Slunná 16, Brno, 617 00Czech Republic

www.asamuel.eue-mail: office@asamuel.eutelefon: +420 534 008 052

Fax: +420 545 233 606

Knowledge - Creativity - Dedication - Success

www.asamuel.eu

Who we are?

Documents

Why are we here?. Who are we? Who is our neighbour?

We Are How We Are Found Changes Who We Are

Who we are

Who are we? Who are you?

We Are Who We Are EP107

Who are we???

Who are we????

Who Are We? Where Are We Going?

Brand Identity and Graphic Design We are who we wear. We are what we eat. We are who we listen to. We are what we see

Who do we think we are?Who do we think we are? · Who do we think we are?Who do we think we are? ... one company. Use May Robert’s ... To ask and answer questions and to select

WHO WE ARE

Who we are?

who are we

WHO WE ARE:

Who are we? The Basque Country Who are we? 400.000 population

Who are we?

Who we are…

Who We Are Reading When We Are Reading Haruki Murakamijaits.jpn.org/home/kaishi2014/14_005-karashima.pdf · Who We Are Reading When We Are Reading Haruki Murakami: ... Who We Are

Who we are What We do Who we can help

¿Who are we?